Skip to main content
logo
Enovis Corporation (LON:0I1B)
London flag London · Delayed Price · Currency is GBP · Price in USD
30.73
-0.17 (-0.55%)
At close: Oct 17, 2025

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
United States Revenue
1.28B1.25B
Log In
Log In
Log In
Upgrade
Foreign Locations Revenue
905.36M861.95M
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.19B2.11B
Log In
Log In
Log In
Upgrade

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
U.S. Bracing & Support Revenue
483.14M469.32M
Log In
Log In
Log In
Upgrade
U.S. Other P&R Revenue
273.89M270.74M
Log In
Log In
Log In
Upgrade
International P&R Revenue
367.32M357.90M
Log In
Log In
Log In
Upgrade
Total Prevention & Recovery Revenue
1.12B1.10B
Log In
Log In
Log In
Upgrade
U.S. Reconstructive Revenue
527.19M505.62M
Log In
Log In
Log In
Upgrade
International Reconstructive Revenue
538.04M504.05M
Log In
Log In
Log In
Upgrade
Total Reconstructive Revenue
1.07B1.01B
Log In
Log In
Log In
Upgrade
Total Medical Technology Revenue
2.19B2.11B
Log In
Log In
Log In
Upgrade
Revenue (Other)
-2.19B-2.11B
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.19B2.11B
Log In
Log In
Log In
Upgrade

Adjusted EBITDA

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Prevention & Recovery Adjusted EBITDA
168.17M159.60M
Log In
Log In
Log In
Upgrade
Reconstructive Adjusted EBITDA
231.23M216.92M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-1.16B-1.15B
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-760.05M-775.72M
Log In
Log In
Log In
Upgrade

Capital Expenditures

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Prevention & Recovery Capital Expenditures
-34.00M
Log In
Log In
Log In
Upgrade
Reconstructive Capital Expenditures
-146.71M
Log In
Log In
Log In
Upgrade
Total Medical Technology Capital Expenditures
-180.71M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Year Ending
-9 - 0
Updated Jul 4, 2025. Data Source: Fiscal.ai.